Kidney Cancer Coverage from Every Angle

Rana R. McKay, MD, on the Treatment Landscape for Metastatic RCC

Posted: Monday, February 22, 2021

Rana R. McKay, MD, of the University of California, San Diego, discusses the many treatment options for patients with advanced renal cell carcinoma, including nivolumab and ipilimumab, which kickstarted the shift in treatment 3 years ago, as well as cabozantinib, lenvatinib, everolimus, sunitinib, axitinib, and avelumab. Dr. McKay also describes the big unknown in the field: how best to select the right therapy for the right patient.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.